Skip to content

Clinical trials

Observational Liver Cirrhosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Phase: Observational Country / region: United States Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20101
20112
20122
20134
20152
20161
20173
201811
20198
20205
20214
20228
20234
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting9
Active, not recruiting8
Unknown status7
Terminated5
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Helio Genomics3
Arbor Research Collaborative for Health2
Icahn School of Medicine at Mount Sinai2
Massachusetts General Hospital2
Northwestern University2
Olympus Corporation of the Americas2
Stanford University2
University of Michigan2
University of Wisconsin, Madison2
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis63
Liver Diseases16
Fibrosis11
Non-alcoholic Fatty Liver Disease11
Carcinoma, Hepatocellular9
Fatty Liver9
Hypertension, Portal7
Liver Neoplasms6
Hepatitis C4
Hemorrhage3

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.